Last week, a US Food and Drug Administration (FDA) advisory committee (AdCom) voted against approval of Danish drugmaker ...

The US Food and Drug Administration (FDA) has notified Bayer that it has extended the review period for the New Drug ...

US pharma major Bristol Myers Squibb revealed it has appointed Dr Cristian Massacesi as executive vice president, chief ...

It has been a stellar week for Abivax, a French biotech developing therapeutics that harness the body’s natural regulatory ...

Swiss pharma major Novartis (NOVN: VX) has entered into an exclusive option and license deal with Matchpoint Therapeutics to ...

The Trump administration has asked the US Supreme Court to allow the National Institutes of Health (NIH) to resume canceling ...

Chief executive Thomas Schinecker believes the price of drugs in the USA could be lowered considerably if this model were ...

Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

TCG Labs Soleil has secured another $400 million to expand its global R&D footprint and help build out its growing portfolio ...

The European Medicines’ (EMA) human medicines committee (CHMP) has recommended seven novel medicines for approval at its July ...

Privately-held Swiss biotech Memo Therapeutics has announced results from its Phase II trial evaluating potravitug, a ...

French drugmaker Ipsen announced that the European Commission (EC) has approved Cabometyx (cabozantinib) for adult patients ...